Reuters logo
BRIEF-NanoCarrier signs license preferential negotiating rights agreement with AccuRna
December 4, 2017 / 6:16 AM / 9 days ago

BRIEF-NanoCarrier signs license preferential negotiating rights agreement with AccuRna

Dec 4 (Reuters) - NanoCarrier Co Ltd :

* Says it and AccuRna Inc entered into a preferential negotiating rights agreement on exclusive right to license of drug development based on co’s gene delivery technology

* Co will get payment from AccuRna according to the agreement

* Co also plans to inject capital into AccuRna Inc

Source text in Japanese: goo.gl/W9Adf9

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below